Stock Update (NYSE:BMY): Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis® (apixaban) at the ESC Congress 2014

[Business Wire] – Bristol-Myers Squibb Company and Pfizer Inc. announced today that they will present 14 abstracts at the ESC Congress 2014, organized by the European Society of Cardiology, to be held August . . . → Read More: Stock Update (NYSE:BMY): Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis® (apixaban) at the ESC Congress 2014 Similar Articles: Bristol-Myers Squibb Company (NYSE:BMY) – Bristol-Myers Squibb Reports First Quarter 2014 Financial Results Company Update (NYSE:BMY): Bristol-Myers Squibb Ranks First on 2014 Best Corporate Citizens List Stock Update (NYSE:BMY): U.S. FDA Approves Eliquis® (apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery